Thermo Fisher Scientific Inc., a Waltham company that supplies laboratory and scientific instruments, said Thursday that its adjusted earnings per share in the fourth quarter grew 14 percent to a record $1.36, as revenues increased 6 percent to a record $3.26 billion.
New product launches and growth in China were among the reasons cited by the company for its performance in 2012.
In a statement, Marc N. Casper, president and chief executive of Thermo Fisher Scientific, said, “Our teams executed well in a challenging environment to deliver strong performance in all three of our business segments.
For the full year 2012, adjusted EPS grew 19 percent to a record $4.94, versus $4.16 in 2011. Revenue for 2012 was up 8 percent to $12.51 billion, the company said in a press release.
The release added, “Full year revenue from high-growth Asia-Pacific markets now represents 17 percent of total company revenue, up from 15 percent in 2011; China became the second largest geography by revenue, at more than $700 million in 2012.’’
The company added that it is initiating adjusted EPS and revenue guidance for the full year 2013. The company expects to achieve adjusted EPS in the range of $5.32 to $5.46 for 2013, which would result in 8 percent to 11 percent adjusted EPS growth over 2012. The company expects to achieve 2013 revenue in the range of $12.80 billion to $13.00 billion, for 2 percent to 4 percent revenue growth year over year.
“Looking ahead to 2013, we are planning for the global economic environment to remain challenging,’’ Casper said. “That said, given our performance in 2012 and our proven strategy of delivering top-line growth, using our productivity levers to expand margins and effectively deploying our capital, I’m confident we can deliver another successful year.’’